Reporting Manager
Soleus Capital Management, L.P.
Symbol
JSPR
Shares outstanding
15,004,217 shares
Disclosed Ownership
1,494,420 shares
Ownership
10%
Form type
SCHEDULE 13G/A
Filing time
11 Feb 2025, 16:00:34 UTC
Date of event
31 Dec 2024
Next filing
08 May 2026

Quoteable Key Fact

"Soleus Capital Master Fund, L.P. disclosed 10% ownership in JASPER THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (JSPR) on 31 Dec 2024."

Quick Takeaways

  • Soleus Capital Master Fund, L.P. filed SCHEDULE 13G/A for JASPER THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (JSPR).
  • Disclosed ownership: 10%.
  • Date of event: 31 Dec 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 11 Feb 2025, 16:00.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (9)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Soleus Private Equity Fund III, L.P. 1.3% 200,000 0 200,000 /s/ Guy Levy Guy Levy/Managing Member
Soleus Private Equity GP III, LLC 1.3% 200,000 0 200,000 /s/ Guy Levy Guy Levy/Managing Member
Soleus PE GP III, LLC 1.3% 200,000 0 200,000 /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital Master Fund, L.P. 8.6% 1,294,420 0 1,294,420 /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital, LLC 8.6% 1,294,420 0 1,294,420 /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital Group, LLC 8.6% 1,294,420 0 1,294,420 /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital Management, L.P. 10% 1,494,420 0 1,494,420 /s/ Guy Levy Guy Levy/Managing Member
Soleus GP LLC 10% 1,494,420 0 1,494,420 /s/ Guy Levy Guy Levy/Managing Member
Guy Levy 10% 1,494,420 0 1,494,420 /s/ Guy Levy Guy Levy
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .